TROY FOLIC INJECTION

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

VITAMIN M = FOLIC ACID = PGA

Available from:

TROY LABORATORIES PTY LTD

INN (International Name):

folic acid(15mg/mL)

Pharmaceutical form:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Composition:

VITAMIN M = FOLIC ACID = PGA VITAMIN-M Active 15.0 mg/ml

Units in package:

50mL

Class:

VM - Veterinary Medicine

Manufactured by:

TROY LABORATORIES

Therapeutic group:

DOG | HORSE | BITCH | CASTRATE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT

Therapeutic area:

NUTRITION & METABOLISM

Therapeutic indications:

ANAEMIA

Product summary:

Poison schedule: 0; Withholding period: WHP: MEAT:Nil.; Host/pest details: DOG: [ANAEMIA]; HORSE: [ANAEMIA]; Poison schedule: 0; Withholding period: ; Host/pest details: DOG: [ANAEMIA]; HORSE: [ANAEMIA]; For use in folic acid responsive anaemias in horses and dogs.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

LABEL IMAGE PROUDLY SUPPLIED BY
[e-mail]
------------_._---------------
Draft Text Label:
Troy Folic Injection
Immediate label:
Ancillary
Panel
Text
appearing
abovethe Headerand below the Footerlinesis net
included
in the label
DIRECTIONS FOR USE:
HORSES: 7.5 mL i.rn. DAILY for 4-7 DAYS
DOGS:
1mL
i.m,
daily FOR 4-7 days
MEAT WITHHOLDING PERIOD (HORSES):
NIL
TROY LABORATORIES PTY.
LIMITED
98
LONG ST. SMITHFIELD,
N.SW.
2164 AUSTRALIA
Dispose of empty container by wrapping with paper and puttinq in
garbage.
Protect from
light
Store below 25°C (Air conditioning).
NRA Approval
No.:
_505841_
_0806_
Batch:
25 July 2003
Expiry:
Page 2
of4
~------------------------------
DRAFT
TEXT
LABEL:
TROY
FOLIC
INJECTION
CARTON:
MAIN
PANEL
TEXT
APPEARING
ABOVETHE HEADERAND
BELOW
THE
Pccter
LINES
IS NOL
INCLUDED
IN THE
LABEL
FOR ANIMAL TREATMENT ONLY
TROY
FOLIC INJECTION
ACTIVE CONSTITUENT:
15 mg/mL
FOLIC ACID
FOR USE IN FOLIC ACID RESPONSIVE ANAEMIAS IN HORSES AND
DOGS
25
JULY
2003
PAGE 3
OF4
-~-_._-----~._------------------
•
Draft
Label Text:
Troy
Folic Injection
Leaflet -
DELETED
Text appearing above the
Header
and belowthe Footerlines is nol
included
in the label
DIRECTIONS FOR USE:
HORSES:
7.5 mL i.m. DAILY for 4-7 DAYS
DOGS:
1mL
i.m,
daily FOR 4-7 days
MEAT WITHHOLDING PERIOD (HORSES):
NIL
TROY LABORATORIES PTY. LIMITED
98
LONG ST. SMITHFIELD,
N.SW.
2164 AUSTRALIA
Dispose of empty container by wrapping with paper and putting in
garbage.
Protect from light.
Store below 25°C (Air conditioning).
NRA Approval
No.:
_505841_
abo:'>
Batch:
25 July 2003
Expiry:
Page 4
of4

Summary of Product characteristics

MATERIAL SAFETY DATA SHEET
PRODUCT NAME: TROY FOLIC INJECTION
PAGE: 1 OF 4
THIS REVISION ISSUED: AUGUST, 2005
SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
TROY LABORATORIES PTY. LIMITED ABN: 21 000 283 769
TEL:
[phone]
98 LONG STREET
FAX:
[phone]
SMITHFIELD NSW 2164
SUBSTANCE:
Water solution of folic acid.
TRADE NAME:
TROY FOLIC INJECTION
PRODUCT CODE:
50584
PRODUCT USE:
For use in folic responsive anaemias in dogs and horses.
CREATION DATE:
JULY, 2005
REVISION DATE:
AUGUST, 2005
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of NOHSC
Australia.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S25. Avoid contact with eyes.
SUSDP CLASSIFICATION:
None allocated.
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
EMERGENCY OVERVIEW
PHYSICAL DESCRIPTION & COLOUR
: Clear yellow liquid.
ODOUR:
Mild odour.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
POTENTIAL HEALTH EFFECTS
INHALATION
SHORT TERM EXPOSURE:
Significant inhalation exposure is considered to be unlikely.
Available data indicates that
this product is not harmful. However product may be mildly irritating,
although unlikely to cause anything more than
mild transient discomfort.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. It should
present no hazards in
normal use. In addition product is unlikely to cause any discomfort in
normal use.
LONG TERM EXPOSURE:
No data for health effects associated with long term skin exposure.
EYE CONTACT:
SHORT TERM EXPOSURE
: Exposure via eyes is considered to be unlikely. This product may be
mildly irritating to
eyes, but is unlikely to cause anything more than mild discomfort
which should